GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CareMax Inc (NAS:CMAX) » Definitions » Debt-to-EBITDA

CareMax (CareMax) Debt-to-EBITDA : -0.28 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is CareMax Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

CareMax's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $373.5 Mil. CareMax's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $118.6 Mil. CareMax's annualized EBITDA for the quarter that ended in Dec. 2023 was $-1,761.7 Mil. CareMax's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.28.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for CareMax's Debt-to-EBITDA or its related term are showing as below:

CMAX' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -24.08   Med: 0.86   Max: 10.48
Current: -0.83

During the past 4 years, the highest Debt-to-EBITDA Ratio of CareMax was 10.48. The lowest was -24.08. And the median was 0.86.

CMAX's Debt-to-EBITDA is ranked worse than
100% of 423 companies
in the Healthcare Providers & Services industry
Industry Median: 2.61 vs CMAX: -0.83

CareMax Debt-to-EBITDA Historical Data

The historical data trend for CareMax's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CareMax Debt-to-EBITDA Chart

CareMax Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
2.55 10.48 -24.08 -0.83

CareMax Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.52 -1.55 -17.96 -1.47 -0.28

Competitive Comparison of CareMax's Debt-to-EBITDA

For the Health Information Services subindustry, CareMax's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CareMax's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, CareMax's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where CareMax's Debt-to-EBITDA falls into.



CareMax Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

CareMax's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(373.545 + 118.579) / -590.463
=-0.83

CareMax's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(373.545 + 118.579) / -1761.728
=-0.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


CareMax  (NAS:CMAX) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


CareMax Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of CareMax's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


CareMax (CareMax) Business Description

Traded in Other Exchanges
N/A
Address
1000 NW 57th Court, Suite 400, Miami, FL, USA, 33126
CareMax Inc is a technology-enabled care platform providing value-based care and chronic disease management to seniors. It operates various owned medical centers that offer a comprehensive suite of healthcare and social services and a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians across the United States.
Executives
Bryan Cho director 30 HUDSON YARDS, 72ND FLOOR, NEW YORK NY 10001
De La Torre Ralph director, 10 percent owner 4939 BROOKVIEW DRIVE, DALLAS TX 75220
Ryan Oquinn director 1000 NW 57 COURT, SUITE 400, MIAMI FL 33126
Kevin Berg director 345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
Beatriz Maria Assapimonwait director 1000 NW 57 CT., SUITE 400, MIAMI FL 33126
Vincent Omachonu director 1000 NW 57 CT., SUITE 400, MIAMI FL 33126
Jose Ramon Rodriguez director PRIMORIS SERVICES CORPORATION, 2300 NORTH FIELD STREET, SUITE 1900, DALLAS TX 75201
Related Cm Advisor, Llc director 30 HUDSON YARDS, 72ND FLOOR, NEW YORK NY 10001
Imc Holdings, Lp 10 percent owner 525 OKEECHOBEE BOULEVARD, SUITE 1050, WEST PALM BEACH FL 33401
William C. Lamoreaux officer: EVP 1000 NW 57 CT., SUITE 400, MIAMI FL 33126
Kevin Wirges officer: EVP, Treasurer and CFO 1000 NW 57 CT., SUITE 400, MIAMI FL 33126
De Solo Carlos A. director, officer: President and CEO 1000 NW 57 CT., SUITE 400, MIAMI FL 33126
Randy Simpson director C/O GLENVIEW CAPITAL MANAGEMENT, LLC, 767 FIFTH AVENUE, 44TH FLOOR, NEW YORK NY 10153
Solo Alberto De officer: EVP and COO 1000 NW 57 CT., SUITE 400, MIAMI FL 33126
Jennifer L. Carter director C/O DFP SPONSOR LLC, 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017